-
1
-
-
0029759025
-
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
-
Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.
-
(1996)
N Engl J Med
, vol.335
, pp. 453-461
-
-
Grodstein, F.1
Stampfer, M.J.2
Manson, J.E.3
Colditz, G.A.4
Willett, W.C.5
Rosner, B.6
Speizer, F.E.7
Hennekens, C.H.8
-
2
-
-
0042594633
-
Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
-
for the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group
-
Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH for the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003; 349: 535-45.
-
(2003)
N Engl J Med
, vol.349
, pp. 535-545
-
-
Hodis, H.N.1
Mack, W.J.2
Azen, S.P.3
Lobo, R.A.4
Shoupe, D.5
Mahrer, P.R.6
Faxon, D.P.7
Cashin-Hemphill, L.8
Sanmarco, M.E.9
French, W.J.10
Shook, T.L.11
Gaarder, T.D.12
Mehra, A.O.13
Rabbani, R.14
Sevanian, A.15
Shil, A.B.16
Torres, M.17
Vogelbach, K.H.18
Selzer, R.H.19
-
3
-
-
0035035574
-
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000
-
Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000. Fertil Steril 2001; 75: 898-915.
-
(2001)
Fertil Steril
, vol.75
, pp. 898-915
-
-
Godsland, I.F.1
-
4
-
-
23244440781
-
Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial
-
Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian A, Hodis HN. Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005; 12: 366-73.
-
(2005)
Menopause
, vol.12
, pp. 366-373
-
-
Karim, R.1
Mack, W.J.2
Lobo, R.A.3
Hwang, J.4
Liu, C.R.5
Liu, C.H.6
Sevanian, A.7
Hodis, H.N.8
-
7
-
-
0032893058
-
Hormone replacement therapy, inflammation, and hemostasis in elderly women
-
Cushman M, Meilahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy RP. Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol 1999; 19: 893-9.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 893-899
-
-
Cushman, M.1
Meilahn, E.N.2
Psaty, B.M.3
Kuller, L.H.4
Dobs, A.S.5
Tracy, R.P.6
-
8
-
-
0027441963
-
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
-
Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
-
(1993)
Lancet
, vol.342
, pp. 1076-1079
-
-
Meade, T.W.1
Ruddock, V.2
Stirling, Y.3
Chakrabarti, R.4
Miller, G.J.5
-
9
-
-
0032513756
-
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
-
Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. Jama 1998; 279: 1477-82.
-
(1998)
Jama
, vol.279
, pp. 1477-1482
-
-
Danesh, J.1
Collins, R.2
Appleby, P.3
Peto, R.4
-
10
-
-
0345535125
-
Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study
-
Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study. Eur Heart J 2003; 24: 567-76.
-
(2003)
Eur Heart J
, vol.24
, pp. 567-576
-
-
Kofoed, S.C.1
Wittrup, H.H.2
Sillesen, H.3
Nordestgaard, B.G.4
-
11
-
-
0030249162
-
The human fibrinolytic system
-
Chandler WL. The human fibrinolytic system. Crit Rev Oncol Hematol 1996; 24: 27-45.
-
(1996)
Crit Rev Oncol Hematol
, vol.24
, pp. 27-45
-
-
Chandler, W.L.1
-
12
-
-
0030803068
-
Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated TPA antigen in patients with high PAI-1 activity levels
-
Chandler WL, Alessi MC, Aillaud MF, Henderson P, Vague P, Juhan-Vague I. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: Relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation 1997; 96: 761-8.
-
(1997)
Circulation
, vol.96
, pp. 761-768
-
-
Chandler, W.L.1
Alessi, M.C.2
Aillaud, M.F.3
Henderson, P.4
Vague, P.5
Juhan-Vague, I.6
-
13
-
-
3042748693
-
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events
-
Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004; 109: 6-19.
-
(2004)
Circulation
, vol.109
, pp. 6-19
-
-
Ridker, P.M.1
Brown, N.J.2
Vaughan, D.E.3
Harrison, D.G.4
Mehta, J.L.5
-
14
-
-
3242662502
-
Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women
-
Pradhan AD, LaCroix AZ, Langer RD, Trevisan M, Lewis CE, Hsia JA, Oberman A, Kotchen JM Ridker PM. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women. Circulation 2004; 110: 292-300.
-
(2004)
Circulation
, vol.110
, pp. 292-300
-
-
Pradhan, A.D.1
LaCroix, A.Z.2
Langer, R.D.3
Trevisan, M.4
Lewis, C.E.5
Hsia, J.A.6
Oberman, A.7
Kotchen, J.M.8
Ridker, P.M.9
-
15
-
-
0028832052
-
Association of fibrinolytic parameters with early atherosclerosis
-
The ARIC Study. Atherosclerosis Risk in Communities Study
-
Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 284-90.
-
(1995)
Circulation
, vol.91
, pp. 284-290
-
-
Salomaa, V.1
Stinson, V.2
Kark, J.D.3
Folsom, A.R.4
Davis, C.E.5
Wu, K.K.6
-
16
-
-
20444473788
-
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study
-
Langer RD, Pradhan AD, Lewis CE, Manson JE, Rossouw JE, Hendrix SL, LaCroix AZ, Ridker PM. Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study. Thromb Haemost 2005; 93: 1108-16.
-
(2005)
Thromb Haemost
, vol.93
, pp. 1108-1116
-
-
Langer, R.D.1
Pradhan, A.D.2
Lewis, C.E.3
Manson, J.E.4
Rossouw, J.E.5
Hendrix, S.L.6
LaCroix, A.Z.7
Ridker, P.M.8
-
17
-
-
0037154329
-
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women
-
Brown NJ, Abbas A, Byrne D, Schoenhard JA, Vaughan DE. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation 2002; 105: 304-9.
-
(2002)
Circulation
, vol.105
, pp. 304-309
-
-
Brown, N.J.1
Abbas, A.2
Byrne, D.3
Schoenhard, J.A.4
Vaughan, D.E.5
-
19
-
-
0025378934
-
Structure and ligand binding properties of human serum albumin
-
Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990; 37: 57-84.
-
(1990)
Dan Med Bull
, vol.37
, pp. 57-84
-
-
Kragh-Hansen, U.1
-
20
-
-
0034947438
-
The stabilized plaque: Will the dream come true?
-
Hansson GK. The stabilized plaque: Will the dream come true? Eur Heart J Suppl 2001; 3: C69-C75.
-
(2001)
Eur Heart J Suppl
, vol.3
-
-
Hansson, G.K.1
-
21
-
-
0035808009
-
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial
-
for the Estrogen in the Prevention of Atherosclerosis Trial Research Group
-
Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP for the Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 135: 939-53.
-
(2001)
Ann Intern Med
, vol.135
, pp. 939-953
-
-
Hodis, H.N.1
Mack, W.J.2
Lobo, R.A.3
Shoupe, D.4
Sevanian, A.5
Mahrer, P.R.6
Selzer, R.H.7
Liu Cr, C.R.8
Liu Ch, C.H.9
Azen, S.P.10
-
23
-
-
0020561529
-
Measurement of crosslinked fibrin degradation products, an immunoassay using monoclonal antibodies
-
Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN. Measurement of crosslinked fibrin degradation products, an immunoassay using monoclonal antibodies. Thromb Haemost 1983; 50: 591-4.
-
(1983)
Thromb Haemost
, vol.50
, pp. 591-594
-
-
Elms, M.J.1
Bunce, I.H.2
Bundesen, P.G.3
Rylatt, D.B.4
Webber, A.J.5
Masci, P.P.6
Whitaker, A.N.7
-
24
-
-
33745551242
-
Gerinnungsphysiologische Schnellmethode zu Bestimmung des Fibrinogens
-
Clauss A. Gerinnungsphysiologische Schnellmethode zu Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-45.
-
(1957)
Acta Haematol
, vol.17
, pp. 237-245
-
-
Clauss, A.1
-
25
-
-
0027215682
-
Passage of the menopause is followed by haemostatic changes
-
Lindoff C, Petersson F, Lecander I, Martinsson G, Astedt B. Passage of the menopause is followed by haemostatic changes. Maturitas 1993; 17: 17-22.
-
(1993)
Maturitas
, vol.17
, pp. 17-22
-
-
Lindoff, C.1
Petersson, F.2
Lecander, I.3
Martinsson, G.4
Astedt, B.5
-
26
-
-
0028960526
-
Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study
-
Gebara OC, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, Welty FK, Wilson PW, Levy D, Muller JE, Tofler GH. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995; 91: 1952-8.
-
(1995)
Circulation
, vol.91
, pp. 1952-1958
-
-
Gebara, O.C.1
Mittleman, M.A.2
Sutherland, P.3
Lipinska, I.4
Matheney, T.5
Xu, P.6
Welty, F.K.7
Wilson, P.W.8
Levy, D.9
Muller, J.E.10
Tofler, G.H.11
-
27
-
-
0029737825
-
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII
-
Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol 1996; 16: 1170-6.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1170-1176
-
-
Scarabin, P.Y.1
Vissac, A.M.2
Kirzin, J.M.3
Bourgeat, P.4
Amiral, J.5
Agher, R.6
Guize, L.7
-
28
-
-
27944446881
-
Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: The Estrogen in the Prevention of Atherosclerosis Trial
-
Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: The Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005; 12: 728-33.
-
(2005)
Menopause
, vol.12
, pp. 728-733
-
-
Steiner, A.Z.1
Hodis, H.N.2
Lobo, R.A.3
Shoupe, D.4
Xiang, M.5
Mack, W.J.6
-
29
-
-
3042686391
-
Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis
-
Chapman CML, Beilby JP, McQuillan BM, Thompson PL, Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004; 35: 1619-24.
-
(2004)
Stroke
, vol.35
, pp. 1619-1624
-
-
Chapman, C.M.L.1
Beilby, J.P.2
McQuillan, B.M.3
Thompson, P.L.4
Hung, J.5
-
30
-
-
0029164510
-
Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
-
Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1995; 15: 1263-8.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1263-1268
-
-
Levenson, J.1
Giral, P.2
Razavian, M.3
Gariepy, J.4
Simon, A.5
-
31
-
-
0028587689
-
Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease
-
Agewall S, Wikstrand J, Suurkula M, Tengborn L, Fagerberg B. Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagul Fibrinolysis 1994; 5: 895-904.
-
(1994)
Blood Coagul Fibrinolysis
, vol.5
, pp. 895-904
-
-
Agewall, S.1
Wikstrand, J.2
Suurkula, M.3
Tengborn, L.4
Fagerberg, B.5
-
32
-
-
0027264924
-
Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study
-
Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb 1993; 13: 661-8.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 661-668
-
-
Willeit, J.1
Kiechl, S.2
-
33
-
-
0025785580
-
Risk factors for early carotid atherosclerosis in middle-aged French women
-
Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb 1991; 11: 966-72.
-
(1991)
Arterioscler Thromb
, vol.11
, pp. 966-972
-
-
Bonithon-Kopp, C.1
Scarabin, P.Y.2
Taquet, A.3
Touboul, P.J.4
Malmejac, A.5
Guize, L.6
-
34
-
-
0024431367
-
Prediction of carotid stenosis progression by lipid and hematologic measurements
-
Grotta JC, Yatsu FM, Pettigrew LC, Rhoades H, Bratina P, Vital D, Alam R, Earls R, Picone C. Prediction of carotid stenosis progression by lipid and hematologic measurements. Neurology 1989; 39: 1325-31.
-
(1989)
Neurology
, vol.39
, pp. 1325-1331
-
-
Grotta, J.C.1
Yatsu, F.M.2
Pettigrew, L.C.3
Rhoades, H.4
Bratina, P.5
Vital, D.6
Alam, R.7
Earls, R.8
Picone, C.9
-
35
-
-
0024242248
-
Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland
-
Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988; 8: 788-92.
-
(1988)
Arteriosclerosis
, vol.8
, pp. 788-792
-
-
Salonen, R.1
Seppanen, K.2
Rauramaa, R.3
Salonen, J.T.4
-
36
-
-
5644248267
-
Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): Association with the intimal-medial thickness of carotid arteries
-
Sakata T, Mannami T, Baba S, Kokubo Y, Kario K, Okamoto A, Kumeda K, Ohkura N, Katayama Y, Miyata T, Tomoike H, Kato H. Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): Association with the intimal-medial thickness of carotid arteries. Atherosclerosis 2004; 176: 355-60.
-
(2004)
Atherosclerosis
, vol.176
, pp. 355-360
-
-
Sakata, T.1
Mannami, T.2
Baba, S.3
Kokubo, Y.4
Kario, K.5
Okamoto, A.6
Kumeda, K.7
Ohkura, N.8
Katayama, Y.9
Miyata, T.10
Tomoike, H.11
Kato, H.12
-
37
-
-
0034036476
-
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography
-
Mack WJ, LaBree L, Liu C, Selzer RH, Hodis HN. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis 2000; 150: 371-9.
-
(2000)
Atherosclerosis
, vol.150
, pp. 371-379
-
-
Mack, W.J.1
LaBree, L.2
Liu, C.3
Selzer, R.H.4
Hodis, H.N.5
-
38
-
-
0037016038
-
Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study
-
Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002; 106: 2919-24.
-
(2002)
Circulation
, vol.106
, pp. 2919-2924
-
-
Djousse, L.1
Rothman, K.J.2
Cupples, L.A.3
Levy, D.4
Ellison, R.C.5
-
39
-
-
0024286990
-
Albumin-an important extracellular antioxidant?
-
Halliwell B. Albumin-an important extracellular antioxidant? Biochem Pharmacol 1988; 37: 569-71.
-
(1988)
Biochem Pharmacol
, vol.37
, pp. 569-571
-
-
Halliwell, B.1
-
40
-
-
10344266010
-
Serum albumin is a specific inhibitor of apoptosis in human endothelial cells
-
Zoellner H, Hofler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, Wojta J, Fabry A, Lockie S, Binder BR. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109: 2571-80.
-
(1996)
J Cell Sci
, vol.109
, pp. 2571-2580
-
-
Zoellner, H.1
Hofler, M.2
Beckmann, R.3
Hufnagl, P.4
Vanyek, E.5
Bielek, E.6
Wojta, J.7
Fabry, A.8
Lockie, S.9
Binder, B.R.10
-
41
-
-
0347480267
-
Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study
-
Post MS, van der Mooren MJ, van Baal WM, Blankenstein MA, Merkus HMWM, Kroeks MVAM, Franke HR, Kenemans P, Stehouwer CDA. Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study. Am J Obstet Gynecol 2003; 189: 1221-7.
-
(2003)
Am J Obstet Gynecol
, vol.189
, pp. 1221-1227
-
-
Post, M.S.1
van der Mooren, M.J.2
van Baal, W.M.3
Blankenstein, M.A.4
Merkus, H.M.W.M.5
Kroeks, M.V.A.M.6
Franke, H.R.7
Kenemans, P.8
Stehouwer, C.D.A.9
|